Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Regeneron Pharmaceuticals
Scientific Title
A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Based Chemotherapy in First Line Treatment of Patients With Advanced or Metastatic PD L1+Non-small Cell Lung Cancer